Comment on: "Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comment on: "Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis"

Published:2022-05 Issue:3 Volume:74 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

SALCICCIA Stefano,SCIARRA Alessandro,CATTARINO Susanna,MARIOTTI Gianna,BEVILACQUA Giulio,GENTILUCCI Alessandro

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2022N03A0360

Reference13 articles.

1. Mottet N, van den Bergh RC. Prostate Cancer: European Association of Urology (EAU) Guidelines; 2021 [Internet]. Available from: https://uroweb.org/guideline/prostate-cancer [cited 2022, Mar 16].

2. Castration-resistance prostate cancer: what is in the pipeline?;Presicce C;Minerva Urol Nefrol,2018

3. Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide

4. Innovations in imaging modalities for recurrent and metastatic prostate cancer: a systematic review

5. Managing Nonmetastatic Castration-resistant Prostate Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP